The ICD-10 code for a complete metabolic panel is Z13228, which was established in the 2025 edition, effective from October 1, 2024.
This code is specifically used for billing and diagnostic purposes.
Also worth reading: What is the process for Michigan residents to complete a relative insurance attestation? · How to lower car insurance Dubai in 2026? · What is the definitive AI insurance regulatory compliance checklist for brokers in 2026?
A complete metabolic panel (CMP) is a group of 14 blood tests that provide crucial information about a person's metabolism, including electrolyte and fluid balance, kidney function, and liver function.
The CMP is typically ordered during routine health examinations and can help detect a variety of disorders, especially those affecting the liver, kidneys, and metabolic function.
The CMP includes tests for glucose, calcium, electrolytes (such as sodium, potassium, and bicarbonate), blood urea nitrogen (BUN), creatinine, albumin, total protein, and liver enzymes (such as AST and ALT).
The code Z13228 is classified under "encounters for screening for other metabolic disorders," which highlights its use in preventive health care rather than just for symptomatic patients.
There was a transition from ICD-9 to ICD-10 coding systems, which introduced a more detailed classification of diseases and conditions, allowing for better tracking of health trends and resource allocation.
The CMP is frequently used in conjunction with other tests like the complete blood count (CBC) to provide a comprehensive overview of a patient’s health status.
The development of the CMP allows healthcare providers to detect conditions such as diabetes, kidney disease, and liver disease at an earlier stage, improving treatment outcomes.
The LOINC code for the CMP is 243238, which standardizes the identification of laboratory tests across different health systems, facilitating data exchange and electronic health records.
Each component of the CMP serves a specific purpose; for example, elevated glucose levels may indicate diabetes, while abnormal liver enzyme levels could suggest liver damage or disease.
The transition to ICD-10 has increased the number of codes from around 14,000 in ICD-9 to over 68,000 in ICD-10, allowing for more specific and nuanced coding of diseases and conditions.
The use of electronic health records (EHRs) has streamlined the process of coding and billing, as these systems often integrate clinical decision support tools that suggest appropriate ICD-10 codes based on lab results.
The CMP is one of the most commonly ordered tests in clinical settings, illustrating its importance in routine health assessments and disease screening.
The comprehensive metabolic panel can help assess the effects of medications on organ function, particularly for patients undergoing treatment for chronic conditions.
In addition to diagnostic purposes, the CMP is useful for monitoring the health of patients undergoing treatments like chemotherapy, which can impact metabolic function and organ health.
The specific tests included in the CMP may vary slightly by laboratory, but they generally follow the established guidelines to ensure consistency and reliability across different health care institutions.
The classification of metabolic disorders in the ICD-10 system allows for better research and understanding of these conditions, contributing to advancements in medical knowledge and treatment options.
The comprehensive metabolic panel is not just a single test; it represents a complex interplay of various biochemical markers that reflect the body’s physiological status, making it a vital tool in clinical diagnostics.
Understanding the implications of each component of the CMP is essential for healthcare providers as they interpret results and make informed decisions regarding patient care.
The evolution of coding systems like ICD-10 reflects advancements in our understanding of diseases, emphasizing the importance of precise diagnostics in improving public health outcomes.